You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC

New Guidelines in Pulmonary Hypertension: The Experts Discuss

  • Authors: Vallerie V. McLaughlin, MD; Sean P. Gaine, MD, PhD, FRCPI; Stephan Rosenkranz, MD
  • CME / ABIM MOC Released: 10/18/2022
  • Valid for credit through: 10/18/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.50 ABIM MOC points

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for an international audience of non-US cardiologists, pulmonologists, and rheumatologists.

The goal of this activity is for learners to be better able to describe important updates related to pulmonary arterial hypertension (PAH) derived from the 2022 European Society of Cardiology/European Respiratory Society (ESC/ERS) guidelines on the diagnosis and treatment of pulmonary hypertension, and their potential clinical implications.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Changes to the 2022 PH guidelines
  • Have greater competence related to
    • Diagnosing PAH based on the latest guidelines
    • Selecting treatment approaches for PAH based on the latest guidelines


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Moderator

  • Vallerie V. McLaughlin, MD

    Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
    Associate Chief Clinical Officer, Cardiovascular Services
    University of Michigan Medical Group
    Director, Pulmonary Hypertension Program
    Michigan Medicine/University of Michigan
    Ann Arbor, Michigan, United States

    Disclosures

    Vallerie V. McLaughlin, MD, has the following relevant financial relationships:
    Consultant or advisor for: Acceleron; Actelion; Aerovate; Altavant; Bayer; Caremark; Gossamer Bio; Liquidia; Merck; United Therapeutics
    Research funding from: Acceleron; Actelion; Altavant; Reata; Sonvie
    Stock options from: Clene

Panelists

  • Sean P. Gaine, MD, PhD, FRCPI

    Professor of Medicine
    Consultant Respiratory Physician
    National Pulmonary Hypertension Unit
    Mater Misericordiae University Hospital
    University College Dublin
    Dublin, Ireland

    Disclosures

    Sean P. Gaine, MD, PhD, FRCPI, has the following relevant financial relationships:
    Speaker or member of speakers bureau for: Actelion; Bayer; Janssen
    Research funding from: Janssen
    Other: Independent contractor for: Acceleron; Actelion; Bayer; Janssen; United Therapeutics

  • Stephan Rosenkranz, MD

    Professor
    Department of Cardiology, Pulmonology, and Intensive Care Medicine
    Center for Molecular Medicine Cologne
    Cologne Cardiovascular Research Center
    Heart Center at the University of Cologne
    Cologne, Germany

    Disclosures

    Stephan Rosenkranz, MD, has the following relevant financial relationships:
    Consultant or advisor for: Actelion; AstraZeneca; Bayer; Janssen; Merck Sharp & Dohme, Corp.
    Speaker or member of speakers bureau for: Actelion; AstraZeneca; Bayer; Boehringer Ingelheim; Janssen; Merck Sharp & Dohme, Corp.; Vifor
    Research funding from: Actelion; AstraZeneca; Bayer; Janssen
    Contracted researcher for: Lempo

Editors

  • George Boutsalis, PhD

    Senior Director, Content Development, Medscape, LLC

    Disclosures

    George Boutsalis, PhD, has no relevant financial relationships.

  • Frederick Stange, DO

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Frederick Stange, DO, has no relevant financial relationships.

Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Yaisanet Oyola, MD, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC

New Guidelines in Pulmonary Hypertension: The Experts Discuss

Authors: Vallerie V. McLaughlin, MD; Sean P. Gaine, MD, PhD, FRCPI; Stephan Rosenkranz, MDFaculty and Disclosures

CME / ABIM MOC Released: 10/18/2022

Valid for credit through: 10/18/2023

processing....

 

 

  • Print